"HLA-DRB1 Chains" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of HLA-DRB beta chains that includes over one hundred allele variants. The HLA-DRB1 subtype is associated with several of the HLA-DR SEROLOGICAL SUBTYPES.
| Descriptor ID |
D059811
|
| MeSH Number(s) |
D12.776.395.550.509.400.440.200.010 D12.776.543.550.440.400.440.200.010 D23.050.301.500.400.400.440.200.010 D23.050.301.500.450.400.440.333.500 D23.050.705.552.410.400.440.200.010 D23.050.705.552.450.400.440.333.500
|
| Concept/Terms |
HLA-DRB1 Chains- HLA-DRB1 Chains
- Chains, HLA-DRB1
- HLA DRB1 Chains
- HLA-DRB1 Antigen
- Antigen, HLA-DRB1
- HLA DRB1 Antigen
- HLA DRB1
- HLA-DRB1
|
Below are MeSH descriptors whose meaning is more general than "HLA-DRB1 Chains".
Below are MeSH descriptors whose meaning is more specific than "HLA-DRB1 Chains".
This graph shows the total number of publications written about "HLA-DRB1 Chains" by people in this website by year, and whether "HLA-DRB1 Chains" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 4 | 4 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 4 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 2 | 3 |
| 2017 | 4 | 3 | 7 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 2 | 2 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "HLA-DRB1 Chains" by people in Profiles.
-
Haploidentical Versus Mismatched Unrelated Donor Hematopoietic Cell Transplantation: HLA Factors and Donor Age Considerations. Transplant Cell Ther. 2024 Sep; 30(9):909.e1-909.e11.
-
HLA molecular mismatches and induced donor-specific tolerance in combined living donor kidney and hematopoietic stem cell transplantation. Front Immunol. 2024; 15:1377535.
-
Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis. Mult Scler. 2024 Mar; 30(3):308-315.
-
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proc Natl Acad Sci U S A. 2023 09 05; 120(36):e2302720120.
-
Gene-environment interactions increase the risk of paediatric-onset multiple sclerosis associated with household chemical exposures. J Neurol Neurosurg Psychiatry. 2023 07; 94(7):518-525.
-
Fucosylation of HLA-DRB1 regulates CD4+ T cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy. Nat Cancer. 2023 02; 4(2):222-239.
-
Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution. Mult Scler. 2022 08; 28(9):1330-1339.
-
Genome-wide association study of circulating interleukin 6 levels identifies novel loci. Hum Mol Genet. 2021 04 27; 30(5):393-409.
-
TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019 12 19; 4(24).
-
Autoantibodies Directed Toward a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes. Diabetes. 2019 09; 68(9):1819-1829.